WinHealth International Holding Group Company Limited

维健国际控股集团有限公司

China-based pharmaceutical company focused on kidney diseases, developing, manufacturing and commercializing drugs for kidney and hematologic, respiratory and dermatologic diseases in China.

Filings

The documents are on HKEXnews; we link to the originals.

Matters the filing discloses

From the company’s latest filing; open a kind of matter to see how other companies disclosed it.

• Customer concentration
• Supplier concentration
• Overlapping customers and suppliers
• Distribution model
• Single product, business line or region
• Pricing policy and price changes
• Overseas markets and operations
• Particular sales arrangements
• Business changes and acquisitions
• Seasonality and cyclicality
• Losses and path to profitability
• Net current liabilities or net liabilities
• Inventory level and ageing
• Goodwill, intangibles and asset impairment
• Preferred shares and fair-value liabilities
• Indebtedness, guarantees and other contingent obligations
• Adverse change after the track record
• Non-IFRS measures and adjustments
• Non-recurring gains and losses